Outcome of Board meeting held on today April 28, 2025

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.8%Reaction day

₹275.25

prior close

₹304.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+10.9% vs market

Pharmaceuticals peers, median of 146sector-0.6%+11.4% vs sector

On the reaction day the stock moved 10.9 pts more than Nifty Microcap 250 and 11.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+4.4

10m

+2.7

15m

+2.7

30m

+2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.8-0.1+10.9-0.6+11.4

Next day

+12.3-2.3+14.6-2.1+14.3

+9.4-2.4+11.7-1.9+11.2

+4.0-1.0+4.9-1.0+5.0

—-3.6—-3.8—

—-2.3—-2.8—

+1.0-3.3+4.3-4.5+5.5

15d

+7.9+7.4+0.5+2.9+5.0

+0.6+9.2-8.6+4.4-3.8

+4.3+12.9-8.6+3.0+1.2

-0.9+12.1-13.0+3.8-4.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 146Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Trident Lifeline's board, meeting on April 28, 2025, approved audited financial results for H2 and FY ended March 31, 2025. Standalone Net Sales grew about 50% to Rs. 6,719.91 lacs from Rs. 4,465.24 lacs, while Total Income rose to Rs. 7,757.14 lacs (vs Rs. 7,094 lacs). Standalone Net Profit jumped roughly 85% to Rs. 1,305.14 lacs (vs Rs. 704.34 lacs), taking EPS to Rs. 11.35 from Rs. 6.23. Consolidated performance was even stronger, with Net Sales nearly doubling to Rs. 8,696.47 lacs and PAT at Rs. 1,174.79 lacs (vs Rs. 634.39 lacs). Statutory auditor A Bafna & Associates issued an unmodified opinion on both sets of results, and DAC & Co. was appointed as the new Internal Auditor for FY26.

Likely market impact

Strong topline and bottomline growth in both standalone and consolidated books signals healthy business momentum for shareholders. The clean audit opinion and absence of any governance concerns should be viewed positively by retail investors.